MID TO LATE STAGE TRIAL

Athira Pharma's Alzheimer's drug fails in mid-to-late stage trial

The experimental drug, fosgonimeton, failed to reach statistical significance in a test that measures cognition and other functions, compared to placebo at 26 weeks.